[Kinetics of C-reactive protein release in different forms of acute coronary syndrome].

Instituto de Ciencias del Corazón (ICICOR), Hospital Clínico Universitario de Valladolid, Ramón y Cajal 3, 47005 Valladolid, Spain.
Revista Espa de Cardiologia (Impact Factor: 3.2). 05/2006; 59(5):441-7. DOI: 10.1016/S1885-5857(06)60792-5
Source: PubMed

ABSTRACT Better knowledge of C-reactive protein (CRP) kinetics could lead to improved clinical application of this biomarker.
We studied 110 patients: 42 had ST-elevation acute myocardial infarction (STEMI), 35 had non-ST-elevation acute myocardial infarction (NSTEMI), and 33 had unstable angina. Patients were admitted to our institution within 6 hours of symptom onset. The levels of CRP, troponin-I, and creatine kinase MB fraction (CK-MB) were measured on admission and every 6 hours during the first 48 h. The CRP level was also measured daily until hospital discharge.
The median (interquartile range) CRP level increased relative to baseline from 6 hours after admission, from 5 (2-9) mg/L to 6 (3-10) mg/L (P=.004). Although, CRP levels on admission were similar in all groups, there was a significant difference in peak CRP level: it was 67 (36-112) mg/L in the STEMI group, 29 (20-87) mg/L in the NSTEMI group, and 18 (12-36) mg/L in the unstable angina group. The maximum CRP level was observed 49 (38-53) hours after the onset of symptoms, but occurred later in patients with STEMI. Although there was only a weak non-significant correlation between CRP and troponin levels (r=0.135) at admission, the maximum CRP level was found to be influenced by the degree of myocardial damage (r=0.496; P< .001).
The pattern of CRP release observed was clearly different in different forms of acute coronary syndrome. Although the CRP level measured at admission was similar in all patient groups, it was influenced by the degree of early myocardial tissue necrosis. This variation in CRP kinetics should be taken into consideration when designing future studies.

  • Source
    Revista Espa de Cardiologia 09/2007; 60(8):797-800. · 3.20 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Inflammation and infectious agents such as Chlamydia pneumoniae have been associated with cardiovascular disease. To evaluate the serum high sensitivity C-reactive protein (hs-CRP) and antibodies against Chlamydia pneumoniae and Chlamydial heat shock protein-60 (Cp-HSP-60) in patients with ischemic heart disease (IHD). 62 patients with IHD having either acute myocardial infarction (AMI; n=31) or unstable angina (UA; n=31) and 31 sex- and age- matched healthy subjects as a control group were enrolled in this study. Serum samples of participants were tested for the presence of hs-CRP and antibodies against C. pneumoniae and Cp-HSP-60 using ELISA method. The seroprevalence of anti-C. pneumoniae antibody in AMI group (93.5%) or UA group (90.3%) was significantly higher than the control group (61.3%; p<0.001). The seroprevalence of anti-Cp-HSP60 IgG was 22.6% in healthy subjects with mean end titer of 43.1+/-6.32. The seropositive rates of anti-Cp-HSP60 were 48.4%, 54.8% and 51.6% in AMI, UA and the overall IHD groups with mean end titers of 94+/-22.86, 113.8+/-24.25 and 103.9+/-16.57, respectively. Both the seroprevalence and the mean titer of anti-Cp-HSP60 in patients groups were significantly higher than those observed in the control group (p<0.04 and p<0.03, respectively). Moreover, the mean serum hs-CRP levels was significantly higher in the IHD group as compared to the control group (21.6 microg/ml+/-3.73 vs 2.5 microg/ml+/-0.52; p<0.00001). The mean serum hs-CRP levels of AMI (30.3 microg/ml+/-6.07) or UA (12.9 microg/ml+/-3.85) groups were also significantly higher than those observed in the control group (p<0.00001 and p<0.001, respectively). Furthermore, the difference of the mean serum hs-CRP levels between AMI and UA groups was also significant (p<0.02). These results showed that the seroprevalence of antibodies against C. pneumoniae and Cp-HSP-60 and the serum levels of hs-CRP and anti-Cp-HSP60 IgG were higher in patients with IHD.
    Iranian journal of immunology: IJI 04/2008; 5(1):51-6.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: High-sensitivity CRP (hsCRP) is being increasingly used as a marker for cardiac risk assessment and as a prognostic tool in acute coronary syndrome. We analyzed the relation between hsCRP values at admission and in-hospital outcomes in 98 consecutive patients with acute myocardial infarction (AMI) undergoing catheterization. Patients with cardiac events had more advanced Killip class, more proportion of depressed left ventricular ejection fraction (LVEF), higher Global Registry of Acute Coronary Events (GRACE) risk score, and higher hsCRP levels. High-sensitivity CRP and GRACE risk score showed a significant positive correlation (r = .320, P = .002). In multivariate analysis, hsCRP resulted as a predictor of worse in-hospital outcomes independently of GRACE risk score (OR 1.122, CI95%:1.005-1.252, P = .040). The hsCRP value showing the maximum likelihood ratio for predicting cardiac events was 1.45 mg/dL. High levels of hsCRP were also associated with development of contrast-induced nephropathy but not with bleeding events.
    Angiology 05/2011; 63(1):30-4. · 2.37 Impact Factor

Full-text (2 Sources)

Available from
Jun 10, 2014